276 related articles for article (PubMed ID: 25425582)
1. Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility.
Toledo RA; Hatakana R; Lourenço DM; Lindsey SC; Camacho CP; Almeida M; Lima JV; Sekiya T; Garralda E; Naslavsky MS; Yamamoto GL; Lazar M; Meirelles O; Sobreira TJ; Lebrao ML; Duarte YA; Blangero J; Zatz M; Cerutti JM; Maciel RM; Toledo SP
Endocr Relat Cancer; 2015 Feb; 22(1):65-76. PubMed ID: 25425582
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of RET gene should be performed in patients with multiple endocrine neoplasia type 2 (MEN 2) syndrome and no apparent genotype-phenotype correlation: an appraisal of p.Y791F and p.C634Y RET mutations in five unrelated Brazilian families.
Valente FO; Dias da Silva MR; Camacho CP; Kunii IS; Bastos AU; da Fonseca CC; Simião HP; Tamanaha R; Maciel RM; Cerutti JM
J Endocrinol Invest; 2013 Dec; 36(11):975-81. PubMed ID: 23723040
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of RET Y791F carriers in Denmark 1994-2017: A National Cohort Study.
Høxbroe Michaelsen S; Ornstrup MJ; Poulsen MM; Bennedbaek FN; Gaustadnes M; Rossing M; Darling P; Vestergaard P; Mathiesen JS
J Surg Oncol; 2019 May; 119(6):687-693. PubMed ID: 30644554
[TBL] [Abstract][Full Text] [Related]
4.
Qi XP; Jin BY; Li PF; Wang S; Zhao YH; Cao ZL; Yu XH; Cheng J; Fang XD; Zhao JQ
Thyroid; 2019 Oct; 29(10):1447-1456. PubMed ID: 31364476
[No Abstract] [Full Text] [Related]
5. Medullary Thyroid Carcinoma Associated with Germline RET
Xu JY; Grubbs EG; Waguespack SG; Jimenez C; Gagel RF; Sosa JA; Sellin RV; Dadu R; Hu MI; Trotter CS; Jackson M; Rich TA; Hyde SM; Sherman SI; Cote GJ
Thyroid; 2016 Dec; 26(12):1744-1751. PubMed ID: 27673361
[TBL] [Abstract][Full Text] [Related]
6. Germline sequence variant S836S in the RET proto-oncogene is associated with low level predisposition to sporadic medullary thyroid carcinoma in the Spanish population.
Ruiz A; Antiñolo G; Fernández RM; Eng C; Marcos I; Borrego S
Clin Endocrinol (Oxf); 2001 Sep; 55(3):399-402. PubMed ID: 11589684
[TBL] [Abstract][Full Text] [Related]
7. Modifying impact of
Kaczmarek-Ryś M; Ziemnicka K; Pławski A; Budny B; Michalak M; Hryhorowicz S; Hoppe-Gołębiewska J; Boruń P; Gołąb M; Czetwertyńska M; Sromek M; Szalata M; Ruchała M; Słomski R
Endocr Relat Cancer; 2018 Apr; 25(4):421-436. PubMed ID: 29386230
[TBL] [Abstract][Full Text] [Related]
8. High penetrance of pheochromocytoma associated with the novel C634Y/Y791F double germline mutation in the RET protooncogene.
Toledo RA; Wagner SM; Coutinho FL; Lourenço DM; Azevedo JA; Longuini VC; Reis MT; Siqueira SA; Lucon AM; Tavares MR; Fragoso MC; Pereira AA; Dahia PL; Mulligan LM; Toledo SP
J Clin Endocrinol Metab; 2010 Mar; 95(3):1318-27. PubMed ID: 20080836
[TBL] [Abstract][Full Text] [Related]
9. Retroposed copies of RET gene: a somatically acquired event in medullary thyroid carcinoma.
Bim LV; Navarro FCP; Valente FOF; Lima-Junior JV; Delcelo R; Dias-da-Silva MR; Maciel RMB; Galante PAF; Cerutti JM
BMC Med Genomics; 2019 Jul; 12(1):104. PubMed ID: 31288802
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
[TBL] [Abstract][Full Text] [Related]
11. The occurrence and the type of germline mutations in the RET gene in patients with medullary thyroid carcinoma and their unaffected kindred's from Central Poland.
Paszko Z; Sromek M; Czetwertynska M; Skasko E; Czapczak D; Wisniewska A; Prokurat A; Chrupek M; Jagielska A; Kozlowicz-Gudzinska I
Cancer Invest; 2007 Dec; 25(8):742-9. PubMed ID: 18058472
[TBL] [Abstract][Full Text] [Related]
12. p.Val804Met, the Most Frequent Pathogenic Mutation in RET, Confers a Very Low Lifetime Risk of Medullary Thyroid Cancer.
Loveday C; Josephs K; Chubb D; Gunning A; Izatt L; Tischkowitz M; Ellard S; Turnbull C
J Clin Endocrinol Metab; 2018 Nov; 103(11):4275-4282. PubMed ID: 29590403
[TBL] [Abstract][Full Text] [Related]
13. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.
Moore SW; Appfelstaedt J; Zaahl MG
J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543
[TBL] [Abstract][Full Text] [Related]
14. RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center.
Elisei R; Romei C; Cosci B; Agate L; Bottici V; Molinaro E; Sculli M; Miccoli P; Basolo F; Grasso L; Pacini F; Pinchera A
J Clin Endocrinol Metab; 2007 Dec; 92(12):4725-9. PubMed ID: 17895320
[TBL] [Abstract][Full Text] [Related]
15. Codon Y791F mutations in a large kindred: is prophylactic thyroidectomy always indicated?
Vestergaard P; Vestergaard EM; Brockstedt H; Christiansen P
World J Surg; 2007 May; 31(5):996-1001; discussion 1002-4. PubMed ID: 17483988
[TBL] [Abstract][Full Text] [Related]
16. Mutational spectrum of multiple endocrine neoplasia type 2 and sporadic medullary thyroid carcinoma in taiwan.
Chang CF; Yang WS; Su YN; Wu IL; Chang TC
J Formos Med Assoc; 2009 May; 108(5):402-8. PubMed ID: 19443294
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of somatic RAS mutations in medullary thyroid cancer - a Polish population study.
Oczko-Wojciechowska M; Pfeifer A; Rusinek D; Pawlaczek A; Zebracka-Gala J; Kowalska M; Kowal M; Swierniak M; Krajewska J; Gawlik T; Chmielik E; Czarniecka A; Szpak-Ulczok S; Jarząb B
Endokrynol Pol; 2015; 66(2):121-5. PubMed ID: 25931041
[TBL] [Abstract][Full Text] [Related]
18. M918V RET mutation causes familial medullary thyroid carcinoma: study of 8 affected kindreds.
Martins-Costa MC; Cunha LL; Lindsey SC; Camacho CP; Dotto RP; Furuzawa GK; Sousa MS; Kasamatsu TS; Kunii IS; Martins MM; Machado AL; Martins JR; Dias-da-Silva MR; Maciel RM
Endocr Relat Cancer; 2016 Dec; 23(12):909-920. PubMed ID: 27807060
[TBL] [Abstract][Full Text] [Related]
19. Variability in Medullary Thyroid Carcinoma in
Mathiesen JS; Nielsen SG; Rasmussen ÅK; Kiss K; Wadt K; Hermann AP; Nielsen MF; Larsen SR; Brusgaard K; Frederiksen AL; Godballe C; Rossing M
Front Endocrinol (Lausanne); 2020; 11():251. PubMed ID: 32411094
[No Abstract] [Full Text] [Related]
20. Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre.
Bugalho MJ; Domingues R; Santos JR; Catarino AL; Sobrinho L
Surgery; 2007 Jan; 141(1):90-5. PubMed ID: 17188172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]